Skip to main content
. 2022 Apr 23;11(9):2379. doi: 10.3390/jcm11092379

Table 8.

Summary of subjective and objective dry-eye parameters in patients who did not perform lid hygiene. (A) Summary of subjective symptoms of 1st and 2nd examination. (B) Summary of objective signs of 1st and 2nd examination.

(A)
DM 1–4 (N = 238) DM-1 (N =103) DM-2 (N = 83) DM-3 (N = 31) DM-4 (N = 21)
Exam Median IQR p Median IQR p Median IQR p Median IQR p Median IQR p
SPEED (total) 1st 11.0 8.0 0.087 12.0 8.0 0.179 11.0 7.0 0.265 10.0 7.0 0.883 10.0 8.0 0.458
2nd 10.0 8.0 10.0 8.0 11.0 8.0 10.0 9.0 7.0 7.0
Frequency (SPEED) 1st 5.0 3.0 0.062 5.0 3.0 0.312 5.0 3.0 0.154 4.0 3.0 0.726 5.0 3.0 0.308
2nd 4.5 4.0 5.0 4.0 5.0 2.0 4.0 4.0 4.0 3.5
Severity (SPEED) 1st 6.0 4.0 0.149 6.0 4.5 0.155 6.0 4.0 0.437 5.0 5.0 0.980 5.0 5.0 0.726
2nd 5.0 5.0 5.0 5.0 5.0 5.0 5.0 7.0 4.0 4.5
OSDI(total) 1st 36.4 33.1 0.091 37.5 30.0 0.305 36.0 34.3 0.305 31.8 32.7 0.595 32.5 34.0 0.498
2nd 31.3 31.5 31.3 38.9 31.8 27.5 32.5 22.2 29.2 24.9
OSDI (A) 1st 8.0 6.3 0.093 8.0 6.5 0.180 8.0 8.0 0.506 7.0 7.0 0.498 7.0 8.0 0.539
2nd 7.0 7.0 7.0 7.0 7.0 7.0 6.0 5.0 5.0 8.0
OSDI (B) 1st 4.0 5.0 <0.001 4.0 6.0 0.049 4.0 5.0 0.024 3.0 4.0 0.070 3.0 5.0 0.378
2nd 3.0 5.0 4.0 5.0 3.0 3.0 3.0 4.0 2.0 3.5
OSDI (C) 1st 3.0 5.0 0.727 3.0 5.5 0.881 3.0 5.0 0.841 3.0 5.0 0.381 3.0 5.0 0.324
2nd 3.0 4.3 3.0 4.0 3.0 5.0 3.0 7.0 3.0 2.5
(B)
DM 1–4 (N = 238) DM-1 (N =103) DM-2 (N = 83) DM-3 (N = 31) DM-4 (N = 21)
Exam Median IQR p Median IQR p Median IQR p Median IQR p Median IQR p
LLT (nm) 1st 69.0 33.0 0.368 66.0 28.0 0.797 69.0 29.0 0.244 77.0 38.0 0.748 86.0 48.0 0.370
2nd 68.5 36.0 64.0 35.0 67.0 29.0 74.0 34.0 83.0 42.5
MGE 1st 8.0 6.0 0.720 8.0 5.0 0.208 8.0 7.0 0.757 8.0 5.0 0.146 8.0 6.0 0.479
2nd 8.0 6.0 8.0 6.0 8.0 6.0 8.0 6.0 5.0 6.0
Meiboscale
(grade)
1st 1.0 0.5 0.020 1.0 0.5 0.126 1.0 0.5 0.185 1.5 1.0 0.261 1.5 1.0 0.596
2nd 1.5 1.0 1.5 1.0 1.5 1.0 1.5 1.5 1.5 1.0
PB 1st 3.0 5.0 0.004 4.0 5.0 0.331 3.0 5.0 0.051 3.0 4.0 0.176 3.0 4.0 0.029
2nd 2.0 4.0 3.0 5.0 2.0 3.0 2.0 3.0 1.0 3.0
PB (%) 1st 62.5 60.8 0.002 62.5 61.6 0.048 60.0 62.6 0.028 63.1 58.5 0.890 50.0 60.1 0.110
2nd 50.0 63.3 50.0 57.5 48.3 62.3 66.7 63.3 33.3 77.2
TB 1st 6.0 6.0 0.901 7.0 7.0 0.389 6.0 6.0 0.905 6.0 5.0 0.459 6.0 6.0 0.506
2nd 6.0 7.0 7.0 7.0 6.0 7.0 5.0 6.0 4.0 6.0
Schirmer test (mm) 1st 4.0 5.0 0.003 4.0 5.0 0.021 4.0 5.0 0.296 4.0 4.0 0.651 4.0 5.0 0.015
2nd 3.0 5.0 3.0 5.0 4.0 5.0 4.0 4.3 2.0 4.0
FTBUT (sec) 1st 3.0 1.0 0.555 3.0 1.0 0.575 3.0 1.0 0.846 3.0 1.0 0.881 3.0 1.0 0.678
2nd 3.0 1.0 3.0 2.0 3.0 1.0 3.0 1.0 2.0 1.0
SPK (grade) 1st 0.0 0.0 0.187 0.0 0.0 0.030 0.0 0.0 0.815 0.0 1.0 0.647 0.0 0.0 0.672
2nd 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0

DM: dermatochalasis; IQR: interquatile range; MGE: number of expressible meibomian glands; OSDI (A): subtotal of the frequency of symptoms; OSDI (B): subtotal of the frequency of activity limitation; OSDI (C): subtotal of the frequency of environmental factors triggering discomfort; LLT: average lipid-layer thickness; PB: number of partial blinks; B (%): partial blink rate; TB: total number of blinks; FTBUT: fluorescein tear-film break-up time; SPK: superficial punctate keratitis; p: statistical significance using the Friedman tes.